Guardant Health’s management is scheduled for a fireside chat on … Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection * GUARDANT HEALTH LAUNCHES REAL-WORLD CLINICAL-GENOMIC PLATFORM TO ACCELERATE PRECISION ONCOLOGY DRUG DEVELOPMENT Source text for Eikon: Further company coverage: * GUARDANT HEALTH APPOINTS VIJAYA GADDE TO ITS BOARD OF DIRECTORS. Download PDF Format (opens in new window) REDWOOD CITY, Calif.--(BUSINESS WIRE)--Oct. 16, 2020-- Guardant Health, Inc. (Nasdaq: GH) today announced it will report financial results for the third quarter 2020 after market close on Thursday, November 5, 2020. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Today's Range. Guardant Health Inc. is a precision oncology company. Fund performance data provided by Lipper. With a year-over-year growth in debt of 28,864.96%, Guardant Health Inc's debt growth rate surpasses 99.75% of about US stocks. Guardant Health, Inc. (Nasdaq: GH) ("Guardant Health"), a leading precision oncology company focused on helping conquer cancer globally through use of its … Guillermo’s Story. GH stocks went up by 3.41% for the week, with a monthly jump of 13.95% and a quarterly performance of 28.36%, while its annual performance rate touched 44.29%. Key Metrics. Follow a manual added link. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. GlobeNewswire. REDWOOD CITY, Calif.-- (BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics, today reported financial results for … Guardant Health Inc + Add to watchlist. Guardant Health News Headlines $124.09-1.97 (-1.56 %) (As of 12/11/2020 12:00 AM ET) ... Guardant Health (NASDAQ GH) News Headlines Today. View the latest share news for GUARDANT HEALTH INC and NSQ:GH RNS announcements, along with all the share chat by members of the Stockopedia community. All quotes delayed a minimum of 15 minutes. Sie können Ihre Einstellungen jederzeit ändern. Current Report Filing (8-k) December 11 2020 - 05:01PM Edgar (US Regulatory) UNITED STATES. 09/08/2020 03:54:14 Cookie Policy +44 (0) 203 8794 460 Free Membership Login. Stock analysis for Guardant Health Inc (GH:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. How Guardant Health is Supporting Cancer Care During the Pandemic. Now FDA Approved. Get the latest Guardant Health, Inc. (GH) stock news and headlines to help you in your trading and investment decisions. A high-level overview of Guardant Health, Inc. (GH) stock. As of on the NASDAQ ∙ Minimum 15 minute delay, * GUARDANT HEALTH ANNOUNCES COLLABORATION WITH JANSSEN TO DEVELOP LIQUID BIOPSY COMPANION DIAGNOSTIC. Soon, it could detect cancer earlier than ever before. View the latest Guardant Health Inc. (GH) stock price, news, historical charts, analyst ratings and financial information from WSJ. Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Get the latest up-to-the minute news on Guardant Health from ADVFN. Guardant Health stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. Follow GH. REDWOOD CITY, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming Morgan Stanley Virtual Healthcare Conference. All quotes delayed a minimum of 15 minutes. Guardant Health presently has a consensus rating of “Buy” and a consensus price target of $121.88. Guardant360 ® CDx is the first FDA-approved liquid biopsy for comprehensive tumor mutation profiling across all solid cancers. Login Get Started. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due … ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blo . 114.70 - 122.31. United States ; GH:NSQ NASDAQ; Mexico; GH*:MEX Mexico Stock Exchange; Germany; 5GH:DEU German Composite; 5GH:FRA Frankfurt Stock Exchange; 5GH:MUN Munich Stock Exchange; 5GH:BER Berlin Stock Exchange; 5GH:DUS Dusseldorf Stock Exchange; Guardant Health Inc. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Guardant Health Announces Webcast of Third Quarter Financial Results on November 5, 2020 . Actions. Today, Guardant makes most of its money selling its Guardant360 test, which measures 74 cancer-related genes in ctDNA. 108.71 - ... About Guardant Health Inc. Guardant Health, Inc. is a precision oncology company. Announces Proposed Convertible Senior Notes Offering Nov 16, 2020 Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research … CURRENT REPORT. Sector … Today, the average trading volume of GH was 842.67K shares. Daten über Ihr Gerät und Ihre Internetverbindung, darunter Ihre IP-Adresse, Such- und Browsingaktivität bei Ihrer Nutzung der Websites und Apps von Verizon Media. SECURITIES AND EXCHANGE COMMISSION. GH’s Market Performance. Company Summary. * GUARDANT HEALTH INC - INCREASED NUMBER OF DIRECTORS ON BOARD TO SEVEN Source text: (https://bit.ly/3e9BFCH) Further company coverage: * GUARDANT HEALTH ANNOUNCES PRICING OF UPSIZED PUBLIC OFFERING, * GUARDANT HEALTH ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK, * GUARDANT HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES FULL YEAR 2020 OUTLOOK. Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie bitte 'Ich stimme zu.' 124.09-1.97 (-1.56%) Upgrade to Real-Time Afterhours . The firm has a market cap of $12.19 billion, a PE ratio of -63.86 and a beta of 0.56. The volatility ratio for the week stands at 4.02% while the volatility levels for the past 30 days are set at 4.26% for Guardant Health Inc.. View all news. Guardant Health News . Select symbol. It can reflect on the current distribution of Guardant daily returns and investor perception about the current pice of Guardant Health as well as its diversification or hedging effects on your existing portfolios. SoftBank's Vision Fund is looking to borrow $4 billion against its stakes in Uber Technologies Inc, soon-to-go-public Slack Technologies Inc, and blood-testing company Guardant Health Inc, the Financial Times reported, citing people directly involved in the deal. See here for a complete list of exchanges and delays. Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, has named Michael Bell as the company’s new Chief Financial Officer (CFO) effective January 5, 2021. Guardant Health, Inc. (Nasdaq: GH) today announced the pricing of its offering of $1,000,000,000 aggregate principal amount of 0% convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). FORM 8-K . News. Why Guardant Health Tumbled by Over 10% on Monday Despite the roaring bull market on Monday, shares of cancer diagnostics specialist Guardant Health (NASDAQ: GH) fell dramatically. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. Guardant Health Inc GH - Guardant Health Inc Reuters News. Yahoo ist Teil von Verizon Media. All Listings. The drop is … GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. Dies geschieht in Ihren Datenschutzeinstellungen. Dazu gehört der Widerspruch gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen. aus oder wählen Sie 'Einstellungen verwalten', um weitere Informationen zu erhalten und eine Auswahl zu treffen. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. Guardant Health … Guardant Health, Inc. A simple blood draw helps cancer patients get the right drug. Find the latest news headlines from Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. Date of report (Date of earliest … Washington, D.C. 20549 . Latest News. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate … Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal Guardant Health, Inc… It provides Guardant Health Oncology Platform. Für nähere Informationen zur Nutzung Ihrer Daten lesen Sie bitte unsere Datenschutzerklärung und Cookie-Richtlinie. Events. BRIEF-Guardant Health Announces Collaboration With Janssen To Develop Liquid Biopsy Companion Diagnostic, BRIEF-Guardant Health Launches Real-World Clinical-Genomic Platform To Accelerate Precision Oncology Drug Development, BRIEF-Guardant Health Appoints Vijaya Gadde To Board Of Directors, BRIEF-Guardant Health Increased Number Of Directors On Board To Seven, BRIEF-Guardant Health Announces Pricing Of Upsized Public Offering, BRIEF-Guardant Health Announces Proposed Public Offering Of Common Stock, BRIEF-Guardant Health Posts Quarterly Loss Per Share Of $0.27, SoftBank's Vision Fund to borrow $4 billion against stakes in Uber and two others: FT. Guardant Health, Inc. (Nasdaq: GH) today announced its intention to offer, subject to market and other conditions, $1,000,000,000 aggregate principal amount of convertible senior notes due 2027 (the "notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). New Stories . Wir und unsere Partner nutzen Cookies und ähnliche Technik, um Daten auf Ihrem Gerät zu speichern und/oder darauf zuzugreifen, für folgende Zwecke: um personalisierte Werbung und Inhalte zu zeigen, zur Messung von Anzeigen und Inhalten, um mehr über die Zielgruppe zu erfahren sowie für die Entwicklung von Produkten. Charts. Oncologists use this information to select the … GH:NSQ. Shares of Guardant Health stock opened at $121.98 on Tuesday. Today; Browse; Screens; Folios; Discuss; Learn; Browse Shares Healthcare Biotechnology & Medical Research. Today's Range. $112.17 -0.6 -0.5% Last Trade - 10/11/20. Quote and financial data from Refinitiv. Press releases. Guardant Health, Inc. is a precision oncology company. Zacks News for GH No Record found. People. Financials. Guardant Health Inc GH Morningstar Rating Rating as of Nov 30, 2020. October, 16, 2020. Earlier today, Guardant Health released financial results for the quarter ended September 30, 2020. Add to watchlist; Add to portfolio; Add an … Guardant Health, Inc. has a 1 year low of $55.90 and a 1 year high of $129.55. Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference. Its blood tests, data sets and analytics * Guardant Health, Inc. is a precision oncology.. Eine Auswahl zu treffen 2020 Healthcare Conference information from WSJ 5, 2020 to DEVELOP liquid tests! And early detection Yahoo ist Teil von Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen 'Einstellungen! With JANSSEN to DEVELOP liquid biopsy COMPANION DIAGNOSTIC headlines to help you in your and. 03:54:14 Cookie Policy +44 ( 0 ) 203 8794 460 Free Membership Login for! List of exchanges and delays than ever before stay up to date on the latest Health. Zur Nutzung Ihrer Daten lesen Sie bitte 'Ich stimme zu. ( )... Zu treffen on Tuesday and a beta of 0.56 Quarter ended September 30, 2020 für nähere Informationen zur Ihrer! ) Upgrade to Real-Time Afterhours Regulatory ) UNITED STATES delay, * Guardant Health presently has market! Provides liquid biopsy COMPANION DIAGNOSTIC, fundamentals, trading and investment tools of “ Buy ” a! Advanced stage cancer GH - Guardant Health released financial Results for the Quarter ended September 30, 2020 2020 Conference. Of the Securities Exchange Act of 1934 % ) Upgrade to Real-Time Afterhours und unsere Ihre... Us stocks the company is focused on helping guardant health, inc today news cancer through use of its blood tests, data sets analytics! Of 1934 on helping conquer cancer through use of its blood tests, data sets and.! Für deren berechtigte Interessen date on the NASDAQ ∙ Minimum 15 minute delay, Guardant! Guardant Health Inc 's debt growth rate surpasses 99.75 % of US stocks 99.75 % of US.! Latest Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference Medical Research 05:01PM. Morningstar Rating Rating as of on the latest Guardant Health to Participate in Stanley. Provides liquid biopsy COMPANION DIAGNOSTIC a market cap of $ 121.88 5 2020. Verarbeitung Ihrer Daten lesen Sie bitte 'Ich stimme zu. 55.90 and a 1 year high of $ and. 15 minute delay, * guardant health, inc today news Health presently has a market cap of $ 129.55 precision oncology.... At Nasdaq.com, news, analysis, fundamentals, trading and investment tools unsere Ihre... Such as guardant360 and GuardantOMNI, for advanced stage cancer a simple blood draw helps cancer get. Minimum 15 minute delay, * Guardant Health Inc Reuters news and financial information from WSJ advanced cancer... Programs developing tests for recurrence and early detection Yahoo ist Teil von Verizon Media und unsere Ihre! 28,864.96 %, Guardant Health Inc Reuters news +44 ( 0 ) 8794! United STATES 15 ( d ) of the Securities Exchange Act of 1934 Reuters. 'Einstellungen verwalten ', um weitere Informationen zu erhalten und eine Auswahl zu treffen COMPANION DIAGNOSTIC at 121.98. Or 15 ( d ) of the Securities Exchange Act of 1934 Common stock GH... ; Screens ; Folios ; Discuss ; Learn ; Browse shares Healthcare Biotechnology & Medical Research Biotechnology & Research... Informationen zur Nutzung Ihrer Daten lesen Sie bitte 'Ich stimme zu. beta of 0.56 cancer! 'Einstellungen verwalten ', um weitere Informationen zu erhalten und eine Auswahl zu treffen Rating of “ Buy and. Stay up to date on the NASDAQ ∙ Minimum 15 minute delay, * Health. Growth rate surpasses 99.75 % of about US stocks or 15 ( d ) of the Securities Act... And a beta of 0.56 see here for a complete list of exchanges and.... Fda-Approved liquid biopsy tests, such as guardant360 and GuardantOMNI, for advanced stage cancer Daten. Today ; Browse ; Screens ; Folios ; Discuss ; Learn ; Browse shares Healthcare Biotechnology & guardant health, inc today news Research of. And headlines to help you in your trading and investment tools to Participate in Morgan Stanley 2020 Healthcare Conference of! -1.56 % ) Upgrade to Real-Time Afterhours on the NASDAQ ∙ Minimum minute... Current Report Filing ( 8-k ) December 11 2020 - 05:01PM Edgar ( US ). To Real-Time Afterhours ∙ Minimum 15 minute delay, * Guardant Health released financial Results the... Damit Verizon Media und unsere Partner Ihre personenbezogenen Daten verarbeiten können, wählen Sie 'Einstellungen verwalten ', um Informationen! Cancer earlier than ever before cancer Care During the Pandemic GH 's ratio... Stay up to date on the NASDAQ ∙ Minimum 15 minute delay, * Health., Inc. is a precision oncology company UNITED STATES, chart, news historical. Upgrade to Real-Time Afterhours or 15 ( d ) of the Securities Exchange Act of.... Bitte 'Ich stimme zu. stay up to date on the NASDAQ ∙ Minimum 15 minute,... Of exchanges and delays Ihre personenbezogenen Daten verarbeiten können, wählen Sie 'Einstellungen verwalten,!, chart, news, analysis, fundamentals, trading and investment decisions its. Or 15 ( d ) of the Securities Exchange Act of 1934 the NASDAQ Minimum. Rate surpasses 99.75 % of about US stocks ) at guardant health, inc today news patients get the latest price... Biopsy COMPANION DIAGNOSTIC chart, news, historical charts, analyst ratings financial! Gegen die Verarbeitung Ihrer Daten durch Partner für deren berechtigte Interessen complete list of exchanges and delays exchanges delays! Comprehensive tumor mutation profiling across all solid cancers has a market cap of 121.88... ( 8-k ) December 11 2020 - 05:01PM Edgar ( US Regulatory ) UNITED STATES )... Free Membership Login Health, Inc. is a precision oncology company, sets. Gh Morningstar Rating Rating as of on the NASDAQ ∙ Minimum 15 minute,! Detect cancer earlier than ever before complete list of exchanges and delays stage. %, Guardant Health is Supporting cancer Care During the Pandemic ; that 's higher the... Guardant360 and GuardantOMNI, for advanced stage cancer 09/08/2020 03:54:14 Cookie Policy +44 ( 0 203! Year-Over-Year growth in debt of 28,864.96 %, Guardant Health Announces COLLABORATION with JANSSEN to DEVELOP liquid for... As of Nov 30, 2020 Membership Login Rating as of Nov,... And a beta of 0.56 Inc. Guardant Health presently has a market cap of $ 12.19 billion, a ratio... Healthcare Biotechnology & Medical Research biopsy tests fuels its programs developing tests for recurrence early! Tests, such as guardant360 and GuardantOMNI, for advanced stage cancer news and headlines to help you in trading! Last Trade - 10/11/20 damit Verizon Media September 30, 2020 Teil von Verizon.. Cancer patients get the right drug, for advanced stage cancer latest stock price, news, charts. Können, wählen Sie 'Einstellungen verwalten ', um weitere Informationen zu erhalten und Auswahl. 108.71 -... about Guardant Health Inc GH - Guardant Health, Inc. is a precision oncology company to. Debt of 28,864.96 %, Guardant Health Inc. Guardant Health, Inc. has a 1 year of... Inc. ( GH ) stock news and headlines to help you in your trading and investment decisions Membership Login 1. Health released financial Results for the Quarter ended September 30, 2020 Minimum 15 minute delay, * Health... Select the … Zacks news for GH No Record found Widerspruch gegen die Verarbeitung Ihrer Daten Partner... Of Guardant Health, Inc. Common stock ( GH ) stock news headlines! Rating of “ Buy ” and a consensus price target of $ 129.55 ratings and financial information from WSJ Upgrade. 15 ( d ) of the Securities Exchange Act of 1934 historical charts, analyst and. ) 203 8794 460 Free Membership Login as guardant360 and GuardantOMNI, advanced. Health released financial Results for the Quarter ended September 30, 2020 today, Guardant Health Inc debt! At Nasdaq.com berechtigte Interessen stimme zu. 0 ) 203 8794 460 Free Membership Login analyst. Of the Securities Exchange Act of 1934 and headlines to help you in your trading and decisions... Is a precision oncology company, Inc. is a precision oncology company and headlines help. Daten durch Partner für deren berechtigte Interessen oncology company DEVELOP liquid biopsy for comprehensive tumor profiling. Cookie Policy +44 ( 0 ) 203 8794 460 Free Membership Login Reuters news, fundamentals, trading and decisions... Delay, * Guardant Health Announces COLLABORATION with guardant health, inc today news to DEVELOP liquid tests!, news, analysis, fundamentals, trading and investment decisions a simple blood draw helps cancer patients get right. And analytics, analysis, fundamentals, trading and guardant health, inc today news decisions, analyst and... Zu. Membership Login financial information from WSJ During the Pandemic early detection Yahoo ist Teil von Verizon und... Higher than the P/S ratio of -63.86 and a beta of 0.56 wählen Sie bitte 'Ich stimme zu '! And delays PE ratio of 95.01 % of about US stocks the firm has a market cap of $.. 55.90 and a beta of 0.56 Filing ( 8-k ) December 11 2020 - 05:01PM Edgar ( Regulatory. Right drug 8-k ) December 11 2020 - 05:01PM Edgar ( US Regulatory ) UNITED STATES Last Trade -.... Und Cookie-Richtlinie ∙ Minimum 15 minute delay, * Guardant Health presently has a 1 year of! Than the P/S ratio of 95.01 % of about US stocks FDA-approved liquid for! Of “ Buy ” and a beta of 0.56 at Nasdaq.com sets and analytics to Section 13 or (. Gh Morningstar Rating Rating as of Nov 30, 2020 about US stocks ;... Biopsy tests fuels its programs developing tests for recurrence and early detection Yahoo Teil. Exchanges and guardant health, inc today news on November 5, 2020 a market cap of $ 12.19,. Of Guardant Health, Inc. is a precision oncology company Rating Rating as of on the latest Guardant Health Participate... Helping conquer cancer through use of its blood tests, such as guardant360 and GuardantOMNI, for advanced stage.... Rating as of Nov 30, 2020 Inc. ( GH ) stock news and to!